Early detection of pancreatic carcinoma.

[1]  J. Cameron,et al.  Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[2]  R. Hruban,et al.  Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. , 2001, Cancer research.

[3]  K. Lillemoe,et al.  Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Increasingly Recognized Clinicopathologic Entity , 2001, Annals of surgery.

[4]  H. Asakura,et al.  Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  J. Cameron,et al.  Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. , 2001, Cancer research.

[6]  W. Schmiegel,et al.  Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. , 2001, The American journal of pathology.

[7]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[8]  Christopher B Umbricht,et al.  Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR , 2001, The Lancet.

[9]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[10]  U. Alon,et al.  Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. , 2001, Cancer research.

[11]  G. Wright,et al.  Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. , 2001, The American journal of pathology.

[12]  F Graziano,et al.  Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers. , 2001, Cancer research.

[13]  J. Cameron,et al.  Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  J. Jen,et al.  Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. , 2001, Cancer research.

[15]  J. Lutterbaugh,et al.  Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. , 2001, Cancer research.

[16]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[18]  K. Miller,et al.  Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. , 2000, Cancer research.

[19]  K. Horton,et al.  Multidetector CT Angiography in the Evaluation of Pancreatic Carcinoma: Preliminary Observations , 2000, Journal of computer assisted tomography.

[20]  J. Herman,et al.  Predicting lung cancer by detecting aberrant promoter methylation in sputum. , 2000, Cancer research.

[21]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[22]  M. Mann,et al.  Proteomics to study genes and genomes , 2000, Nature.

[23]  G. Klöppel,et al.  Ductal lesions in patients with chronic pancreatitis show K‐ras mutations in a frequency similar to that in the normal pancreas and lack nuclear immunoreactivity for p53 , 2000, Cancer.

[24]  H. Watanabe,et al.  Genetic progression and divergence in pancreatic carcinoma. , 2000, The American journal of pathology.

[25]  E. Petricoin,et al.  Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines , 2000, Electrophoresis.

[26]  M. Choti,et al.  Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. , 2000, The American journal of pathology.

[27]  R. Hruban,et al.  BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications. , 2000, The American journal of pathology.

[28]  R H Hruban,et al.  Hypermethylation of multiple genes in pancreatic adenocarcinoma. , 2000, Cancer research.

[29]  S. Weinberger,et al.  Recent advancements in surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry , 2000, Electrophoresis.

[30]  P. Maisonneuve,et al.  K-ras mutations and benign pancreatic disease , 2000, International journal of pancreatology : official journal of the International Association of Pancreatology.

[31]  R. Hruban,et al.  Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. , 2000, Cancer research.

[32]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[33]  J. Jen,et al.  Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. , 2000, Science.

[34]  S. Reed,et al.  Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. , 2000, Cancer research.

[35]  E. Petricoin,et al.  An approach to proteomic analysis of human tumors , 2000, Molecular carcinogenesis.

[36]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[37]  G. Wright,et al.  Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures , 1999, Prostate Cancer and Prostatic Diseases.

[38]  W. Chapman,et al.  Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[39]  M. Kimmey,et al.  Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer , 1999, Annals of Internal Medicine.

[40]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  L. Grochow,et al.  Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. , 1999, International journal of radiation oncology, biology, physics.

[42]  R. Hruban,et al.  Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. , 1999, The American journal of pathology.

[43]  G. Klöppel,et al.  The K‐ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium , 1999, Cancer.

[44]  J. Celis,et al.  Psoriasin (S100A7): A putative urinary marker for the follow‐up of patients with bladder squamous cell carcinomas , 1999, Electrophoresis.

[45]  T. Yip,et al.  Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. , 1998, Biochimica et biophysica acta.

[46]  E. Strauss.  New Ways to Probe the Molecules of Life , 1998, Science.

[47]  R. Hruban,et al.  Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. , 1998, Cancer research.

[48]  H. Niiyama,et al.  Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer , 1998, American Journal of Gastroenterology.

[49]  E Gabrielson,et al.  Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Suyama,et al.  Endoscopic ultrasound and intraductal ultrasound in the diagnosis of small pancreatic tumors , 1998, Abdominal Imaging.

[51]  R. Hruban,et al.  Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. , 1998, The American journal of pathology.

[52]  M Monden,et al.  Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[53]  T. Tosteson,et al.  K-ras mutation in focal proliferative lesions of human pancreas. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[54]  T. Yip,et al.  Bactericidal domain of lactoferrin: detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry. , 1998, Biochemical and biophysical research communications.

[55]  K. Kinzler,et al.  Identifying markers for pancreatic cancer by gene expression analysis. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[56]  M. Farthing,et al.  A prospective study of K-ras mutations in the plasma of pancreatic cancer patients. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  H. Niiyama,et al.  Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  J. Shay,et al.  Telomerase activity for the preoperative diagnosis of pancreatic cancer. , 1997, Journal of the National Cancer Institute.

[59]  C. Moskaluk,et al.  Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.

[60]  C. Moskaluk,et al.  p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma. , 1997, Cancer research.

[61]  E. Dimagno,et al.  Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. , 1997, Journal of the National Cancer Institute.

[62]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[63]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[64]  R H Hruban,et al.  Familial pancreatic cancer: a review. , 1996, Seminars in oncology.

[65]  S. Kawa,et al.  Comparative study of CA242 and CA19-9 in chronic pancreatitis. , 1996, British Journal of Cancer.

[66]  S. Goodman,et al.  Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms. , 1996, Human pathology.

[67]  H. Pitt,et al.  Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. , 1995, Radiology.

[68]  K. Kinzler,et al.  Serial Analysis of Gene Expression , 1995, Science.

[69]  R. Hartsock,et al.  Human chorionic gonadotropin‐beta subunit gene expression in cultured human fetal and cancer cells of different types and origins , 1995, Cancer.

[70]  A M Goldstein,et al.  Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. , 1995, The New England journal of medicine.

[71]  H. Adami,et al.  Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. , 1995, Journal of the National Cancer Institute.

[72]  S. Goodman,et al.  Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients , 1995, Annals of surgery.

[73]  J. Everhart,et al.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. , 1995, JAMA.

[74]  D S Young,et al.  Clinical applications of two-dimensional electrophoresis. , 1995, Journal of chromatography. A.

[75]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[76]  K. Lillemoe,et al.  Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. , 1994, Journal of the National Cancer Institute.

[77]  L. Tryggvadottir,et al.  Neoplastic diseases in families of breast cancer patients. , 1994, Journal of medical genetics.

[78]  L. Gullo,et al.  Diabetes and the risk of pancreatic cancer. , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[79]  R. Hruban,et al.  Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. , 1994, Cancer research.

[80]  H. Nagura,et al.  Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with positive reactions of carcinoembryonic antigen. , 1994, Archives of pathology & laboratory medicine.

[81]  S. Maeda,et al.  The role ofras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis , 1993 .

[82]  S. Goodman,et al.  K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. , 1993, The American journal of pathology.

[83]  T. Yip,et al.  New desorption strategies for the mass spectrometric analysis of macromolecules , 1993 .

[84]  A. Andrén-sandberg,et al.  Pancreatitis and the risk of pancreatic cancer , 1993 .

[85]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[86]  O. Kronborg,et al.  Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. , 1989, Scandinavian journal of gastroenterology.

[87]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[88]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[89]  A J Krush,et al.  Increased risk of cancer in the Peutz-Jeghers syndrome. , 1987, The New England journal of medicine.

[90]  M. Innis,et al.  alpha-Fetoprotein gene expression. Control of alpha-fetoprotein mRNA levels in cultured rat hepatoma cells. , 1979, The Journal of biological chemistry.

[91]  S. Saga,et al.  Relation of pancreatic duct hyperplasia to carcinoma , 1979, Cancer.

[92]  A. Cubilla,et al.  Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. , 1976, Cancer research.

[93]  D. Boyes,et al.  THE RESULTS OF TREATMENT OF 4389 CASES OF PRECLINICAL CERVICAL SQUAMOUS CARCINOMA , 1970, The Journal of obstetrics and gynaecology of the British Commonwealth.

[94]  S. Sommers,et al.  Pancreatic duct hyperplasia and cancer. , 1954, Gastroenterology.

[95]  G. Bommer,et al.  Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesis , 2004, Virchows Archiv A.

[96]  H. Yamamoto,et al.  Adenocarcinomas with Widespread Microsatellite Instability Genetic and Clinical Features of Human Pancreatic Ductal Updated , 2001 .

[97]  G. Parmigiani,et al.  Advances in Brief Detection of Mitochondrial DNA Mutations in Pancreatic Cancer Offers a “ Mass ”-ive Advantage over Detection of Nuclear DNA Mutations 1 , 2001 .

[98]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[99]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.

[100]  Eric S. Lander.  Array of hope , 1999, Nature Genetics.

[101]  R H Hruban,et al.  Genetics of pancreatic cancer. From genes to families. , 1998, Surgical oncology clinics of North America.

[102]  H. Pitt,et al.  CA 19-9 in pancreatic cancer. , 1998, Surgical oncology clinics of North America.

[103]  J. Seilhamer,et al.  A comparison of selected mRNA and protein abundances in human liver , 1997, Electrophoresis.

[104]  D. Hochstrasser,et al.  Specific sample preparation in colorectal cancer , 1997, Electrophoresis.

[105]  Y. Shiratori,et al.  Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. , 1996, Gastroenterology.

[106]  A. Alaiya,et al.  Sample preparation of human tumors prior to two‐dimensional electrophoresis of proteins , 1995, Electrophoresis.

[107]  T. Hirano,et al.  Characterization of gene expression in clinical lung cancer materials by two‐dimensional polyacrylamide gel electrophoresis , 1994, Electrophoresis.

[108]  J R Siewert,et al.  Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. , 1992, Gastroenterology.

[109]  T. Smyrk,et al.  Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. , 1990, The American journal of gastroenterology.